Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.
about
Biosynthesis of UDP-GlcNAc(3NAc)A by WbpB, WbpE, and WbpD: enzymes in the Wbp pathway responsible for O-antigen assembly in Pseudomonas aeruginosa PAO1Function-biased choice of additives for optimization of protein crystallization - the case of the putative thioesterase PA5185 from Pseudomonas aeruginosa PAO1Structural Analysis of WbpE from Pseudomonas aeruginosa PAO1: A Nucleotide Sugar Aminotransferase Involved in O-Antigen Assembly,The Crystal Structure of OprG from Pseudomonas aeruginosa, a Potential Channel for Transport of Hydrophobic Molecules across the Outer MembraneStructural and Functional Characterization of Pseudomonas aeruginosa CupB ChaperonesStructural basis for the interaction of lipopolysaccharide with outer membrane protein H (OprH) from Pseudomonas aeruginosaToward Understanding the Outer Membrane Uptake of Small Molecules by Pseudomonas aeruginosaDiscovery of an Allosteric Inhibitor Binding Site in 3-Oxo-acyl-ACP Reductase from Pseudomonas aeruginosaInhaled Antibiotics for Gram-Negative Respiratory InfectionsIdentification of small molecule inhibitors of Pseudomonas aeruginosa exoenzyme S using a yeast phenotypic screenEffective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin BThree functional β-carbonic anhydrases in Pseudomonas aeruginosa PAO1: role in survival in ambient airCharacterization of a novel Zn²⁺-dependent intrinsic imipenemase from Pseudomonas aeruginosaAt a supra-physiological concentration, human sexual hormones act as quorum-sensing inhibitorsThe periplasmic protein TolB as a potential drug target in Pseudomonas aeruginosaA Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosaA peptide based on homologous sequences of the β-barrel assembly machinery component BamD potentiates antibiotic susceptibility of Pseudomonas aeruginosa.Alternative folding pathways of the major porin OprF of Pseudomonas aeruginosa.OprG Harnesses the Dynamics of its Extracellular Loops to Transport Small Amino Acids across the Outer Membrane of Pseudomonas aeruginosaSynthesis and biological evaluation of new nanosized aromatic polyamides containing amido- and sulfonamidopyrimidines pendant structures.Elucidation of Mechanisms of Ceftazidime Resistance among Clinical Isolates of Pseudomonas aeruginosa by Using Genomic DataEfflux pump, the masked side of beta-lactam resistance in Klebsiella pneumoniae clinical isolatesProtection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strainsRapid conversion of Pseudomonas aeruginosa to a spherical cell morphotype facilitates tolerance to carbapenems and penicillins but increases susceptibility to antimicrobial peptides.Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.Structural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination.Approaches to the simultaneous inactivation of metallo- and serine-beta-lactamases.Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation.Population structure of clinical Pseudomonas aeruginosa from West and Central African countries.Characterization of the core and accessory genomes of Pseudomonas aeruginosa using bioinformatic tools Spine and AGEntActivity and interactions of antibiotic and phytochemical combinations against Pseudomonas aeruginosa in vitro.Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital.Optimization of antibacterial activity of Perilla frutescens var. acuta leaf against Pseudomonas aeruginosa using the evolutionary operation-factorial design techniqueCeftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.A step towards the discrimination of beta-lactamase-producing clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa by MALDI-TOF mass spectrometry.Inhibition of the production of the Pseudomonas aeruginosa virulence factor pyocyanin in wild-type cells by quorum sensing autoinducer-mimics.The accessory genome of Pseudomonas aeruginosaStructural features governing the activity of lactoferricin-derived peptides that act in synergy with antibiotics against Pseudomonas aeruginosa in vitro and in vivoTracking down antibiotic-resistant Pseudomonas aeruginosa isolates in a wastewater network
P2860
Q24648470-4D979BCF-6017-4BD5-8B63-7998AF98C931Q27658101-7A8B9FB0-A754-40B8-A106-D13A0AC7DD73Q27663161-888DA0B9-D639-4A8F-8756-21C8AEEEA246Q27666153-6FAE1A11-4A3C-4E69-8A11-3862B38BA8D8Q27666914-8AFDE2DC-38AC-486A-916A-AD01246B448FQ27671965-91D97EC7-3E00-46B6-9C12-A1B5387623AEQ27676713-FC387E34-6B72-4DBC-887F-1B0C4C2727F9Q27679901-BFA185C7-67A4-4056-92CC-4C9A37970BA6Q28386160-5B7BEF26-92D7-43B7-B1E4-41A739410E5FQ28472300-C9468538-1BD0-4712-8859-B2C5BEC3E9DEQ28478261-43DC4787-371F-4505-8EA5-0F56F750A6A3Q28492566-8082759D-32DE-4DAC-99A8-B74DD7B07A75Q28492716-A7E79386-E0A6-4510-A6FA-37414FABBD0FQ28537896-61F9D28C-3EE9-44E6-8B1C-600A818977B8Q28541613-D00647A9-3D08-4D17-94B9-2ADDBE4A03D7Q28550146-0AADB50E-E793-4442-9488-1BFCB765FC51Q30155308-9552B1A2-87E5-4288-9A72-40678EAEF504Q30155392-E3EDC01F-3F34-4E24-9E21-E4D4C594BE7EQ30277922-D464D166-4020-4C9C-AE16-424FC091CE20Q30989375-22C8231A-0D65-4542-865E-12EDFED4ED28Q31073879-D73BBDEC-8E47-4AF2-9D0B-6DD01A4F72BCQ33417253-EA6848C4-D9D6-4752-9756-6DA8FB793296Q33523622-55265943-4E07-4443-A87D-777EE580CAA8Q33613660-9FCB3ED2-E611-4504-9956-61E876E67E9DQ33622802-A1DB23F3-27A3-4875-88BF-3840668FB5C5Q33798039-52BDF714-55E8-4D36-B8D0-BF265ED013DAQ33798601-4220A2A8-0BF7-4AAC-929D-8FE2BC2015E7Q33958554-F13580B3-C5F4-452B-8421-E641D755F9FCQ34095684-DBD0DBD9-509E-47F1-B903-B8DACF0C8D28Q34134267-49B0DD89-8AE1-4E30-8B36-5C57E74031D1Q34135922-BA800A05-F085-4B7B-AF27-86BAA00D0977Q34187311-1C5C266C-0552-4085-84C2-C68B16E0C861Q34365963-6563FA4C-A0D5-442E-B9F3-CE4672268339Q34378183-CAE4D55A-E95D-4298-AC15-E0ECC2A1C7C9Q34393008-986426CE-06B9-4016-9868-7B4A19E7D5C3Q34398603-5F6DC90C-AB23-43DB-99A5-A29CB4F69E88Q34422072-6DA6129D-21BC-402B-BE12-734CFCBC08DDQ34431840-366CE285-9EBD-42BC-B191-08A57B1528CBQ34483627-4A0595E3-657F-4522-92CE-8626997CE331Q34531467-6079A355-9A5C-4326-86D7-88D2EDC027E0
P2860
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pseudomonas aeruginosa: resist ...... he turn of the new millennium.
@ast
Pseudomonas aeruginosa: resist ...... he turn of the new millennium.
@en
type
label
Pseudomonas aeruginosa: resist ...... he turn of the new millennium.
@ast
Pseudomonas aeruginosa: resist ...... he turn of the new millennium.
@en
prefLabel
Pseudomonas aeruginosa: resist ...... he turn of the new millennium.
@ast
Pseudomonas aeruginosa: resist ...... he turn of the new millennium.
@en
P2093
P1476
Pseudomonas aeruginosa: resist ...... the turn of the new millennium
@en
P2093
Glupczynski Y
Lebecque P
Malfroot A
Nordmann P
Roussel-Delvallez M
Tulkens PM
Van Eldere J
P304
P356
10.1111/J.1469-0691.2007.01681.X
P577
2007-01-31T00:00:00Z